Vesicular 'omics'
17 January, 2014 by Susan WilliamsonUsing sea urchin eggs as a model system, Professor Jens Coorssen is unveiling the mechanisms underlying the essential cellular process of vesicular release and paving the way for this pathway to be targeted in rational drug development.
Anatomy of an HCV infection
15 January, 2014 by Graeme O'NeillHepatitis C researcher Rowena Bull and her colleagues have provided an intimate account of the surprising behaviour of the hepatitis C virus during the first 100 days of infection. Their findings point towards new strategies to prevent chronic HCV infection, cirrhosis and liver cancer.
GTG CEO extends leave through March
07 January, 2014 by Dylan Bushell-EmblingGenetic Technologies (ASX:GTG) CEO Alison Mew has extended her leave until end-March, and acting chief Tom Howitt will stay in charge in the interim.
New giant clam species discovered
26 November, 2013A new species of giant clam has been found on reefs of the Solomon Islands and Ningaloo in Western Australia.
Body mass may be more nurture than nature
07 November, 2013Genes have less influence on body mass than previously thought.
Generation genome
01 November, 2013 by Susan WilliamsonWhole genome sequencing at birth is soon to arrive in our hospitals, predicts Professor Matt Brown.
Molecular manoeuvring with gesture and voice
18 October, 2013Visualising the structures of complex molecules is now a whole lot easier with a new toolkit.
Melanoma Genome Project on track
17 October, 2013 by Susan WilliamsonThe Melanoma Genome Project is well underway with sequencing data submitted to the International Cancer Genome Consortium repository and expectations this will be publicly available early next year.
Unlocking clues to oesophageal cancer
14 October, 2013Genetic research reveals Barrett's oesophagus and oesophageal cancer are more closely linked than previously thought.
GTG patent upheld for third time
01 October, 2013 by Dylan Bushell-EmblingGenetic Technologies (ASX:GTG) said the US patent office has, for a third time, upheld the validity of claims in one of its non-coding DNA patents.
Blue-green algae linked to motor neuron disease
26 September, 2013The link between neurodegenerative diseases and the consumption of food or water contaminated by blue-green algae has been strengthened with research showing how the algal toxin is misincorporated into proteins.
Lymphatic mispatterning
25 September, 2013 by Fiona WylieNatasha Harvey will head to ComBio this year with a few years’ worth of results and an exciting new story of a protein called Nedd4 and how it could hold a key to vascular networks and their problems.
GTG settles yet another DNA patent suit
18 September, 2013 by Dylan Bushell-EmblingGenetic Technologies (ASX:GTG) has announced the latest settlement in its US patent enforcement efforts and finalised the terms for a proposed US$5m issue of convertible notes.
New genes for an old breed
12 September, 2013A new breeding technique and an old wheat cultivar are combining to produce quality wheat faster.
Unravelling the essentials of the Y chromosome
06 September, 2013 by Susan WilliamsonAn enzyme that 'unravels' DNA plays a key role in male development of the embryo and may provide greater insight into intersex conditions.
